TY - JOUR
T1 - Bacteriologic response to oral Cephalosporins
T2 - Are established susceptibility breakpoints appropriate in the case of acute otitis media?
AU - Dagan, Ron
AU - Abramson, Oren
AU - Leibovitz, Eugene
AU - Greenberg, David
AU - Lang, Ruth
AU - Goshen, Sivan
AU - Yagupsky, Pablo
AU - Leiberman, Alberto
AU - Fliss, Dan M.
PY - 1997/1/1
Y1 - 1997/1/1
N2 - Bacteriologic response to cefuroxime axetil and cefaclor administered for 10 days was evaluated in acute otitis media (AOM) in patients aged 6-36 months. Middle ear fluid culture was obtained by tympanocentesis before treatment, on day 4 or 5 after initiation of treatment, and if clinical relapse occurred before day 17. Bacteriologic failure was observed in 32% of patients receiving cefaclor versus 15% of patients receiving cefuroxime axetil (P = .009). Failure rates increased with increasing MIC: For Streptococcus pneumoniae, 0.5 μg/mL (established as cutoff value for cefuroxime by the National Committee for Clinical Laboratory Standards [NCCLS]) discriminated between success and failure. For Haemophilus influenzae, high failure rates were observed for cefaclor, even with low MICs (≤1.0 μg/mL), and with both drugs they tended to increase with increasing MIC, even for values below the cutoff suggested by the NCCLS (8.0 and 4.0 μg/mL for cefaclor and cefuroxime, respectively). Thus, for AOM caused by H. influenzae, lower susceptibility cutoff levels for MICs should be established.
AB - Bacteriologic response to cefuroxime axetil and cefaclor administered for 10 days was evaluated in acute otitis media (AOM) in patients aged 6-36 months. Middle ear fluid culture was obtained by tympanocentesis before treatment, on day 4 or 5 after initiation of treatment, and if clinical relapse occurred before day 17. Bacteriologic failure was observed in 32% of patients receiving cefaclor versus 15% of patients receiving cefuroxime axetil (P = .009). Failure rates increased with increasing MIC: For Streptococcus pneumoniae, 0.5 μg/mL (established as cutoff value for cefuroxime by the National Committee for Clinical Laboratory Standards [NCCLS]) discriminated between success and failure. For Haemophilus influenzae, high failure rates were observed for cefaclor, even with low MICs (≤1.0 μg/mL), and with both drugs they tended to increase with increasing MIC, even for values below the cutoff suggested by the NCCLS (8.0 and 4.0 μg/mL for cefaclor and cefuroxime, respectively). Thus, for AOM caused by H. influenzae, lower susceptibility cutoff levels for MICs should be established.
UR - http://www.scopus.com/inward/record.url?scp=0030775353&partnerID=8YFLogxK
U2 - 10.1086/514120
DO - 10.1086/514120
M3 - Article
C2 - 9359726
AN - SCOPUS:0030775353
SN - 0022-1899
VL - 176
SP - 1253
EP - 1259
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 5
ER -